Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial)
Although lifestyle interventions are considered the first‐line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in typ...
Saved in:
Published in | Hepatology (Baltimore, Md.) Vol. 58; no. 4; pp. 1287 - 1295 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wolters Kluwer Health, Inc
01.10.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Although lifestyle interventions are considered the first‐line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in type 2 diabetic subjects with NAFLD. In this randomized controlled trial, we compared the 4‐month effects of either AER or RES training on insulin sensitivity (by hyperinsulinemic euglycemic clamp), body composition (by dual‐energy X‐ray absorptiometry), as well as hepatic fat content and visceral (VAT), superficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in‐opposed‐phase magnetic resonance imaging technique) in 31 sedentary adults with type 2 diabetes and NAFLD. After training, hepatic fat content was markedly reduced (P < 0.001), to a similar extent, in both the AER and the RES training groups (mean relative reduction from baseline [95% confidence interval] −32.8% [−58.20 to −7.52] versus −25.9% [−50.92 to −0.94], respectively). Additionally, hepatic steatosis (defined as hepatic fat content >5.56%) disappeared in about one‐quarter of the patients in each intervention group (23.1% in the AER group and 23.5% in the RES group). Insulin sensitivity during euglycemic clamp was increased, whereas total body fat mass, VAT, SSAT, and hemoglobin A1c were reduced comparably in both intervention groups. Conclusion: This is the first randomized controlled study to demonstrate that resistance training and aerobic training are equally effective in reducing hepatic fat content among type 2 diabetic patients with NAFLD. (Hepatology 2013;58:1287–1295) |
---|---|
AbstractList | Although lifestyle interventions are considered the first-line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in type 2 diabetic subjects with NAFLD. In this randomized controlled trial, we compared the 4-month effects of either AER or RES training on insulin sensitivity (by hyperinsulinemic euglycemic clamp), body composition (by dual-energy X-ray absorptiometry), as well as hepatic fat content and visceral (VAT), superficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in-opposed-phase magnetic resonance imaging technique) in 31 sedentary adults with type 2 diabetes and NAFLD. After training, hepatic fat content was markedly reduced (P<0.001), to a similar extent, in both the AER and the RES training groups (mean relative reduction from baseline [95% confidence interval] -32.8% [-58.20 to -7.52] versus -25.9% [-50.92 to -0.94], respectively). Additionally, hepatic steatosis (defined as hepatic fat content >5.56%) disappeared in about one-quarter of the patients in each intervention group (23.1% in the AER group and 23.5% in the RES group). Insulin sensitivity during euglycemic clamp was increased, whereas total body fat mass, VAT, SSAT, and hemoglobin A1c were reduced comparably in both intervention groups. Conclusion: This is the first randomized controlled study to demonstrate that resistance training and aerobic training are equally effective in reducing hepatic fat content among type 2 diabetic patients with NAFLD. (Hepatology 2013;58:1287-1295) [PUBLICATION ABSTRACT] Although lifestyle interventions are considered the first‐line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in type 2 diabetic subjects with NAFLD. In this randomized controlled trial, we compared the 4‐month effects of either AER or RES training on insulin sensitivity (by hyperinsulinemic euglycemic clamp), body composition (by dual‐energy X‐ray absorptiometry), as well as hepatic fat content and visceral (VAT), superficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in‐opposed‐phase magnetic resonance imaging technique) in 31 sedentary adults with type 2 diabetes and NAFLD. After training, hepatic fat content was markedly reduced (P < 0.001), to a similar extent, in both the AER and the RES training groups (mean relative reduction from baseline [95% confidence interval] −32.8% [−58.20 to −7.52] versus −25.9% [−50.92 to −0.94], respectively). Additionally, hepatic steatosis (defined as hepatic fat content >5.56%) disappeared in about one‐quarter of the patients in each intervention group (23.1% in the AER group and 23.5% in the RES group). Insulin sensitivity during euglycemic clamp was increased, whereas total body fat mass, VAT, SSAT, and hemoglobin A1c were reduced comparably in both intervention groups. Conclusion: This is the first randomized controlled study to demonstrate that resistance training and aerobic training are equally effective in reducing hepatic fat content among type 2 diabetic patients with NAFLD. (Hepatology 2013;58:1287–1295) Although lifestyle interventions are considered the first-line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in type 2 diabetic subjects with NAFLD. In this randomized controlled trial, we compared the 4-month effects of either AER or RES training on insulin sensitivity (by hyperinsulinemic euglycemic clamp), body composition (by dual-energy X-ray absorptiometry), as well as hepatic fat content and visceral (VAT), superficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in-opposed-phase magnetic resonance imaging technique) in 31 sedentary adults with type 2 diabetes and NAFLD. After training, hepatic fat content was markedly reduced (P < 0.001), to a similar extent, in both the AER and the RES training groups (mean relative reduction from baseline [95% confidence interval] -32.8% [-58.20 to -7.52] versus -25.9% [-50.92 to -0.94], respectively). Additionally, hepatic steatosis (defined as hepatic fat content >5.56%) disappeared in about one-quarter of the patients in each intervention group (23.1% in the AER group and 23.5% in the RES group). Insulin sensitivity during euglycemic clamp was increased, whereas total body fat mass, VAT, SSAT, and hemoglobin A1c were reduced comparably in both intervention groups. This is the first randomized controlled study to demonstrate that resistance training and aerobic training are equally effective in reducing hepatic fat content among type 2 diabetic patients with NAFLD. Although lifestyle interventions are considered the first-line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in type 2 diabetic subjects with NAFLD. In this randomized controlled trial, we compared the 4-month effects of either AER or RES training on insulin sensitivity (by hyperinsulinemic euglycemic clamp), body composition (by dual-energy X-ray absorptiometry), as well as hepatic fat content and visceral (VAT), superficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in-opposed-phase magnetic resonance imaging technique) in 31 sedentary adults with type 2 diabetes and NAFLD. After training, hepatic fat content was markedly reduced (P < 0.001), to a similar extent, in both the AER and the RES training groups (mean relative reduction from baseline [95% confidence interval] -32.8% [-58.20 to -7.52] versus -25.9% [-50.92 to -0.94], respectively). Additionally, hepatic steatosis (defined as hepatic fat content >5.56%) disappeared in about one-quarter of the patients in each intervention group (23.1% in the AER group and 23.5% in the RES group). Insulin sensitivity during euglycemic clamp was increased, whereas total body fat mass, VAT, SSAT, and hemoglobin A1c were reduced comparably in both intervention groups.UNLABELLEDAlthough lifestyle interventions are considered the first-line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with type 2 diabetes, no intervention studies have compared the effects of aerobic (AER) or resistance (RES) training on hepatic fat content in type 2 diabetic subjects with NAFLD. In this randomized controlled trial, we compared the 4-month effects of either AER or RES training on insulin sensitivity (by hyperinsulinemic euglycemic clamp), body composition (by dual-energy X-ray absorptiometry), as well as hepatic fat content and visceral (VAT), superficial (SSAT), and deep (DSAT) subcutaneous abdominal adipose tissue (all quantified by an in-opposed-phase magnetic resonance imaging technique) in 31 sedentary adults with type 2 diabetes and NAFLD. After training, hepatic fat content was markedly reduced (P < 0.001), to a similar extent, in both the AER and the RES training groups (mean relative reduction from baseline [95% confidence interval] -32.8% [-58.20 to -7.52] versus -25.9% [-50.92 to -0.94], respectively). Additionally, hepatic steatosis (defined as hepatic fat content >5.56%) disappeared in about one-quarter of the patients in each intervention group (23.1% in the AER group and 23.5% in the RES group). Insulin sensitivity during euglycemic clamp was increased, whereas total body fat mass, VAT, SSAT, and hemoglobin A1c were reduced comparably in both intervention groups.This is the first randomized controlled study to demonstrate that resistance training and aerobic training are equally effective in reducing hepatic fat content among type 2 diabetic patients with NAFLD.CONCLUSIONThis is the first randomized controlled study to demonstrate that resistance training and aerobic training are equally effective in reducing hepatic fat content among type 2 diabetic patients with NAFLD. |
Author | Zanolin, Elisabetta Bonora, Enzo Zoppini, Giacomo Moghetti, Paolo Targher, Giovanni Negri, Carlo Faccioli, Niccolò Schena, Federico Bacchi, Elisabetta Lanza, Massimo |
Author_xml | – sequence: 1 givenname: Elisabetta surname: Bacchi fullname: Bacchi, Elisabetta organization: University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 2 givenname: Carlo surname: Negri fullname: Negri, Carlo organization: University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 3 givenname: Giovanni surname: Targher fullname: Targher, Giovanni organization: University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 4 givenname: Niccolò surname: Faccioli fullname: Faccioli, Niccolò organization: Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 5 givenname: Massimo surname: Lanza fullname: Lanza, Massimo organization: University of Verona – sequence: 6 givenname: Giacomo surname: Zoppini fullname: Zoppini, Giacomo organization: University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 7 givenname: Elisabetta surname: Zanolin fullname: Zanolin, Elisabetta organization: University of Verona – sequence: 8 givenname: Federico surname: Schena fullname: Schena, Federico organization: University of Verona – sequence: 9 givenname: Enzo surname: Bonora fullname: Bonora, Enzo organization: University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona – sequence: 10 givenname: Paolo surname: Moghetti fullname: Moghetti, Paolo organization: University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23504926$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1uEzEUhS1URNPAghdAlti0i2n9M5mxl6UEilQJhGBt2Z47xNFkHGwPVXghXpMbkgqpAi9syfc799jnnpGTMY5AyEvOLjlj4moF20vRSC2fkBlfiLaScsFOyIyJllWaS31KznJeM8Z0LdQzciqwXmvRzMivN7GsaIIccrGjB1qSDWMYv1E7dtRCii74v5cJugkhNLQF73tbqI9jgbHQMNKy2wIVtAvWwb6cJ7cGXzK9D2iCj7aDj6s4HJRlR4fwAxLyGWwGel5WQD9fL98KmtA9bsJP6NA72OHiOXna2yHDi-M5J1_fLb_c3FZ3H99_uLm-q7xUSla6sYw3qq2dc75TTvXAlYXaddqCZGphhexU3bKaqZ5p2WB-esGtUx2WQcs5OT_03ab4fYJczCZkD8NgR4hTNryupdStxn1OXj9C13FK-Mc9JTXTHBdSr47U5DbQmW0KG5t25mEECFwdAJ9izgl640PBdDFWTH0wnJn9kA1mbv4MGRUXjxQPTf_FHrvfhwF2_wfN7fLTQfEbVuG26w |
CODEN | HPTLD9 |
CitedBy_id | crossref_primary_10_1186_s13102_024_00972_9 crossref_primary_10_1136_bmjsem_2016_000143 crossref_primary_10_1177_20420188231160394 crossref_primary_10_1152_ajpendo_00019_2020 crossref_primary_10_1016_j_cmet_2023_12_008 crossref_primary_10_1038_srep43029 crossref_primary_10_1002_pdi_2311 crossref_primary_10_3389_fendo_2021_655756 crossref_primary_10_1186_s12889_018_5069_6 crossref_primary_10_1249_MSS_0000000000003199 crossref_primary_10_3389_fendo_2020_592373 crossref_primary_10_1530_JOE_18_0567 crossref_primary_10_1186_s12902_022_01212_2 crossref_primary_10_3390_ijms22073469 crossref_primary_10_1007_s11901_014_0229_3 crossref_primary_10_1080_17512433_2017_1300059 crossref_primary_10_1097_MEG_0000000000001135 crossref_primary_10_1155_2020_6412916 crossref_primary_10_1155_2022_3059629 crossref_primary_10_1016_j_dld_2015_08_004 crossref_primary_10_1080_17461391_2019_1571114 crossref_primary_10_2337_db17_0077 crossref_primary_10_1016_j_bpg_2014_07_008 crossref_primary_10_1016_j_jhep_2015_03_009 crossref_primary_10_5717_jenb_2014_18_3_249 crossref_primary_10_29252_aassjournal_855 crossref_primary_10_1007_s40279_023_01918_w crossref_primary_10_1210_clinem_dgad326 crossref_primary_10_14309_ctg_0000000000000371 crossref_primary_10_4254_wjh_v7_i16_2041 crossref_primary_10_1016_j_artere_2017_07_001 crossref_primary_10_5812_hepatmon_116513 crossref_primary_10_3390_jfmk2040035 crossref_primary_10_1177_2047487318805158 crossref_primary_10_1038_nrendo_2017_173 crossref_primary_10_3390_jcm9041115 crossref_primary_10_1007_s12020_024_03783_7 crossref_primary_10_1002_ueg2_12443 crossref_primary_10_1016_j_pbj_0000000000000002 crossref_primary_10_1159_000360511 crossref_primary_10_1080_13813455_2016_1202985 crossref_primary_10_4103_1110_6611_174717 crossref_primary_10_1016_j_clinthera_2021_01_021 crossref_primary_10_3748_wjg_v25_i28_3669 crossref_primary_10_1111_obr_13727 crossref_primary_10_1016_j_lfs_2022_120522 crossref_primary_10_1016_j_bbrc_2022_03_008 crossref_primary_10_1016_j_conctc_2022_100984 crossref_primary_10_2337_dc16_1728 crossref_primary_10_1007_s11101_023_09912_w crossref_primary_10_1016_j_cld_2023_01_002 crossref_primary_10_1007_s11428_016_0144_z crossref_primary_10_1139_apnm_2018_0635 crossref_primary_10_1586_17474124_2015_1075392 crossref_primary_10_3389_fphar_2016_00283 crossref_primary_10_1097_HC9_0000000000000108 crossref_primary_10_1371_journal_pone_0263931 crossref_primary_10_3390_jcm10081659 crossref_primary_10_1007_s12325_020_01281_6 crossref_primary_10_1016_j_bjpt_2017_06_004 crossref_primary_10_1016_j_jhep_2015_11_004 crossref_primary_10_1152_ajpcell_00144_2024 crossref_primary_10_1016_j_tem_2016_11_006 crossref_primary_10_1186_s13395_023_00333_z crossref_primary_10_3389_fendo_2022_1032164 crossref_primary_10_3390_nu15183950 crossref_primary_10_1111_eci_12958 crossref_primary_10_1152_ajpcell_00405_2024 crossref_primary_10_1002_oby_21890 crossref_primary_10_3904_kjim_2017_343 crossref_primary_10_1136_bjsports_2016_096197 crossref_primary_10_2147_DMSO_S358256 crossref_primary_10_1038_s41598_023_31686_6 crossref_primary_10_1016_j_cgh_2016_04_036 crossref_primary_10_1586_17474124_2014_903798 crossref_primary_10_1007_s00392_020_01709_7 crossref_primary_10_1007_s00125_016_4068_3 crossref_primary_10_1016_j_conctc_2020_100560 crossref_primary_10_1136_bmjgast_2020_000381 crossref_primary_10_4103_tcmj_tcmj_86_20 crossref_primary_10_3390_ijerph19042350 crossref_primary_10_3390_nu15081990 crossref_primary_10_1016_j_ando_2020_05_003 crossref_primary_10_1177_1756283X16638830 crossref_primary_10_2217_pme_14_44 crossref_primary_10_1097_MEG_0000000000002662 crossref_primary_10_3390_physiologia5010010 crossref_primary_10_1177_2047487319850718 crossref_primary_10_3390_nu11122971 crossref_primary_10_2196_11250 crossref_primary_10_1097_MEG_0000000000002887 crossref_primary_10_3389_fendo_2020_00567 crossref_primary_10_1007_s11901_017_0374_6 crossref_primary_10_3389_fendo_2022_1075986 crossref_primary_10_1007_s40279_022_01724_w crossref_primary_10_1007_s10620_016_4126_1 crossref_primary_10_1016_j_gastrohep_2020_05_020 crossref_primary_10_1186_s12986_017_0173_7 crossref_primary_10_1152_japplphysiol_00950_2015 crossref_primary_10_1007_s00125_020_05170_z crossref_primary_10_1002_14651858_CD013156_pub2 crossref_primary_10_1155_2013_805217 crossref_primary_10_1249_JES_0000000000000296 crossref_primary_10_1002_mnfr_202000375 crossref_primary_10_1016_j_lfs_2021_120124 crossref_primary_10_3390_jcm10030467 crossref_primary_10_1016_S2213_8587_24_00377_2 crossref_primary_10_1097_TP_0000000000002483 crossref_primary_10_3389_fmed_2024_1291501 crossref_primary_10_1016_j_clinthera_2021_07_013 crossref_primary_10_1016_j_physbeh_2020_113149 crossref_primary_10_1007_s11332_018_0459_9 crossref_primary_10_20463_jenb_2019_0004 crossref_primary_10_1111_1753_0407_13086 crossref_primary_10_3390_ijms25115571 crossref_primary_10_1016_j_metabol_2016_12_006 crossref_primary_10_14309_ctg_0000000000000316 crossref_primary_10_1016_j_livres_2017_12_008 crossref_primary_10_1186_s12986_024_00871_3 crossref_primary_10_1016_j_livres_2017_12_006 crossref_primary_10_3389_fendo_2023_1081096 crossref_primary_10_1186_s12986_015_0026_1 crossref_primary_10_1002_dmrr_3677 crossref_primary_10_1016_j_metabol_2015_09_017 crossref_primary_10_1002_hep_26475 crossref_primary_10_1016_j_numecd_2020_08_021 crossref_primary_10_1111_liv_14852 crossref_primary_10_1111_liv_70068 crossref_primary_10_1002_hep_26477 crossref_primary_10_3920_CEP200075 crossref_primary_10_1016_j_jhep_2016_06_022 crossref_primary_10_1016_j_bbrc_2024_150305 crossref_primary_10_2337_dc16_1787 crossref_primary_10_1007_s13679_014_0126_7 crossref_primary_10_1016_j_obmed_2020_100233 crossref_primary_10_2147_DMSO_S304357 crossref_primary_10_3748_wjg_v22_i27_6318 crossref_primary_10_5812_hmj_97644 crossref_primary_10_1152_ajpendo_00266_2017 crossref_primary_10_3390_biomedicines9121853 crossref_primary_10_1111_liv_13332 crossref_primary_10_1007_s11332_020_00690_y crossref_primary_10_1038_srep31560 crossref_primary_10_61186_jspac_19946_1_1_54 crossref_primary_10_1016_S0140_6736_23_00773_0 crossref_primary_10_1080_13813455_2021_1886117 crossref_primary_10_3390_nu13010066 crossref_primary_10_1016_j_clnu_2015_07_003 crossref_primary_10_61186_JBUMS_30_3_257 crossref_primary_10_1002_jmri_25845 crossref_primary_10_7570_kjo_2015_24_4_190 crossref_primary_10_1097_MOG_0000000000000060 crossref_primary_10_1002_oby_21032 crossref_primary_10_1007_s10620_016_4083_8 crossref_primary_10_3350_cmh_2018_0086 crossref_primary_10_1016_j_jnutbio_2022_108997 crossref_primary_10_1055_s_0041_1732354 crossref_primary_10_1177_20503121221124762 crossref_primary_10_1111_hepr_12781 crossref_primary_10_3390_ijms22052350 crossref_primary_10_1016_j_metabol_2015_10_032 crossref_primary_10_1586_17474124_2015_965143 crossref_primary_10_3389_fendo_2018_00588 crossref_primary_10_1016_j_gtc_2019_09_003 crossref_primary_10_3390_jcdd9120419 crossref_primary_10_4093_dmj_2019_0034 crossref_primary_10_1111_liv_13311 crossref_primary_10_1007_s00421_014_3031_6 crossref_primary_10_1111_1751_2980_12751 crossref_primary_10_1016_j_molmet_2021_101270 crossref_primary_10_3390_jcm14020428 crossref_primary_10_4158_EP161365_GL crossref_primary_10_1016_j_arteri_2016_06_002 crossref_primary_10_1111_cen_14990 crossref_primary_10_1136_bmjgast_2017_000139 crossref_primary_10_3390_jcm12175603 crossref_primary_10_1016_j_lfs_2021_119639 crossref_primary_10_23949_kjpe_2018_03_57_2_40 crossref_primary_10_1177_20420188221122426 crossref_primary_10_4093_dmj_2020_0010 crossref_primary_10_1016_j_diabres_2018_08_011 crossref_primary_10_1152_ajpendo_00129_2023 crossref_primary_10_5223_pghn_2021_24_1_54 crossref_primary_10_1002_pmic_202300078 crossref_primary_10_1136_bmjsem_2023_001878 crossref_primary_10_1016_j_clinsp_2023_100288 crossref_primary_10_5812_jjcdc_90213 crossref_primary_10_1111_eci_13596 crossref_primary_10_2337_diaspect_28_1_39 crossref_primary_10_1016_S1957_2557_19_30186_5 crossref_primary_10_1055_a_0840_3330 crossref_primary_10_3727_105221617X15124844266408 crossref_primary_10_1111_dme_12725 crossref_primary_10_3390_cells11050872 crossref_primary_10_1186_2193_1801_3_336 crossref_primary_10_2217_pgs_2016_0047 crossref_primary_10_1007_s12020_018_1603_7 crossref_primary_10_1111_jgh_13856 crossref_primary_10_3390_jcm10092040 crossref_primary_10_1111_dom_16019 crossref_primary_10_3389_fnins_2018_00498 crossref_primary_10_1080_00913847_2018_1411171 crossref_primary_10_3164_jcbn_17_115 crossref_primary_10_5812_ijem_109021 crossref_primary_10_1111_jgh_15595 crossref_primary_10_1111_jcmm_12733 crossref_primary_10_1155_2013_309191 crossref_primary_10_3389_fnut_2024_1426551 crossref_primary_10_1016_j_biopha_2017_09_093 crossref_primary_10_3389_fnut_2022_1065188 crossref_primary_10_5717_jenb_2015_15070703 crossref_primary_10_1038_s41430_021_00928_z crossref_primary_10_3350_cmh_2021_0178 crossref_primary_10_1249_MSS_0000000000003388 crossref_primary_10_1016_j_lfs_2020_118868 crossref_primary_10_3904_kjm_2014_86_4_416 crossref_primary_10_1155_2021_5554597 crossref_primary_10_3389_fnut_2021_734859 crossref_primary_10_1002_jmri_25083 crossref_primary_10_1111_obr_13275 crossref_primary_10_1042_BCJ20210185 crossref_primary_10_1007_s00535_014_0959_6 crossref_primary_10_1016_j_jhep_2016_08_019 crossref_primary_10_1016_j_biopha_2021_111803 crossref_primary_10_1123_jpah_2024_0334 crossref_primary_10_1111_joim_13203 crossref_primary_10_1016_j_dsx_2019_07_007 crossref_primary_10_1016_j_tem_2019_07_013 crossref_primary_10_1007_s00125_016_3902_y crossref_primary_10_1016_j_jhep_2016_08_023 crossref_primary_10_3390_nu13093135 crossref_primary_10_1186_s43161_023_00164_5 crossref_primary_10_1093_nutrit_nuy022 crossref_primary_10_1136_bmjdrc_2022_002950 crossref_primary_10_1152_ajpendo_00292_2015 crossref_primary_10_1002_hep_28132 crossref_primary_10_1016_j_lfs_2024_123225 crossref_primary_10_2147_DMSO_S262289 crossref_primary_10_2337_dbi18_0043 crossref_primary_10_1139_apnm_2021_0168 crossref_primary_10_1007_s00125_016_4037_x crossref_primary_10_1007_s00125_018_4618_y crossref_primary_10_1159_000443344 crossref_primary_10_1016_S2213_8587_18_30154_2 crossref_primary_10_1111_1440_1681_13687 crossref_primary_10_1093_advances_nmaa090 crossref_primary_10_1089_met_2022_0069 crossref_primary_10_1177_1756284820941745 crossref_primary_10_1016_j_jshs_2022_01_006 crossref_primary_10_1016_j_dld_2022_12_013 crossref_primary_10_3748_wjg_v20_i36_12956 crossref_primary_10_1177_0300060517707672 crossref_primary_10_1002_jbio_202400274 crossref_primary_10_1016_j_jhep_2015_02_022 crossref_primary_10_3389_fendo_2017_00033 crossref_primary_10_5009_gnl230236 |
Cites_doi | 10.1152/ajpendo.0327.2001 10.1093/clinchem/18.6.499 10.1016/j.jhep.2009.04.012 10.1002/jmri.22580 10.1002/(SICI)1098-2353(1996)9:1<19::AID-CA4>3.0.CO;2-V 10.1016/j.jhep.2009.05.023 10.2337/dc11-1655 10.1136/gut.2006.112094 10.1016/j.jhep.2011.06.010 10.1016/S0730-725X(96)00224-X 10.1097/RLI.0b013e31824baff3 10.1210/jc.2004-1959 10.1038/oby.2003.3 10.1002/hep.22525 10.1097/MOL.0b013e32833ea912 10.1001/jama.2011.576 10.1148/radiology.153.1.6089264 10.1093/ije/dyl245 10.1056/NEJMra0912063 10.1001/jama.286.10.1218 10.1038/nrgastro.2012.200 10.1148/rg.291075123 10.1002/hep.23129 10.2337/dc12-0033 10.1152/ajpendo.00064.2004 10.1136/gut.2011.242073 10.2337/dc11-1583 |
ContentType | Journal Article |
Copyright | Copyright © 2013 by the American Association for the Study of Liver Diseases Copyright © 2013 by the American Association for the Study of Liver Diseases. |
Copyright_xml | – notice: Copyright © 2013 by the American Association for the Study of Liver Diseases – notice: Copyright © 2013 by the American Association for the Study of Liver Diseases. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 H94 K9. 7X8 |
DOI | 10.1002/hep.26393 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1527-3350 |
EndPage | 1295 |
ExternalDocumentID | 3088568001 23504926 10_1002_hep_26393 HEP26393 |
Genre | article Randomized Controlled Trial Journal Article |
GroupedDBID | --- --K .3N .55 .GA .GJ .Y3 05W 0R~ 10A 186 1B1 1CY 1L6 1OB 1OC 1ZS 1~5 24P 31~ 33P 3O- 3SF 3WU 4.4 4G. 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AALRI AANHP AAONW AAQFI AAQQT AAQXK AASGY AAXRX AAXUO AAZKR ABCQN ABCUV ABEML ABIJN ABLJU ABMAC ABOCM ABPVW ABWVN ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACLDA ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADMUD ADNMO ADOZA ADXAS ADZMN ADZOD AECAP AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFFNX AFGKR AFPWT AFUWQ AFZJQ AHMBA AIACR AIURR AIWBW AJAOE AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD F00 F01 F04 F5P FD8 FDB FEDTE FGOYB FUBAC G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IHE IX1 J0M J5H JPC KBYEO KQQ LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 M65 MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ NNB NQ- O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K R2- RGB RIG RIWAO RJQFR ROL RPZ RWI RX1 RYL SEW SSZ SUPJJ TEORI UB1 V2E V9Y W2D W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI X7M XG1 XV2 ZGI ZXP ZZTAW ~IA ~WT AAYXX ABJNI ACZKN AFNMH AGQPQ AHQVU CITATION MEWTI WXSBR ACIJW CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 AAMMB AEFGJ AGXDD AIDQK AIDYY H94 K9. 7X8 |
ID | FETCH-LOGICAL-c3883-96a016874bbbcd8b8fe18ae4bd9ae3085a23d8470408f0936100951ab8de30e93 |
IEDL.DBID | DR2 |
ISSN | 0270-9139 1527-3350 |
IngestDate | Fri Jul 11 07:10:30 EDT 2025 Fri Jul 25 22:57:46 EDT 2025 Thu Apr 03 07:00:55 EDT 2025 Thu Apr 24 23:03:49 EDT 2025 Tue Jul 01 03:33:35 EDT 2025 Wed Jan 22 17:03:14 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | Copyright © 2013 by the American Association for the Study of Liver Diseases. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3883-96a016874bbbcd8b8fe18ae4bd9ae3085a23d8470408f0936100951ab8de30e93 |
Notes | Potential conflict of interest: Nothing to report. Supported in part by grants to Paolo Moghetti from the University of Verona and from the Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy. The funding sources had no involvement in the design, execution or analysis of the study. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.26393 |
PMID | 23504926 |
PQID | 1439091111 |
PQPubID | 996352 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1443397943 proquest_journals_1439091111 pubmed_primary_23504926 crossref_citationtrail_10_1002_hep_26393 crossref_primary_10_1002_hep_26393 wiley_primary_10_1002_hep_26393_HEP26393 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | October 2013 2013-10-00 2013-Oct 20131001 |
PublicationDateYYYYMMDD | 2013-10-01 |
PublicationDate_xml | – month: 10 year: 2013 text: October 2013 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Hepatology (Baltimore, Md.) |
PublicationTitleAlternate | Hepatology |
PublicationYear | 2013 |
Publisher | Wolters Kluwer Health, Inc |
Publisher_xml | – name: Wolters Kluwer Health, Inc |
References | 2001; 286 2010; 33 2010; 59 2005; 90 2011; 60 2010; 363 2011; 34 2012; 35 2012; 56 2007; 56 2007; 36 1957; 35 2009; 29 2003; 11 2010; 21 1984; 153 2009; 51 2011; 305 2005; 288 2009; 50 2002; 283 1997; 15 2008; 48 2012; 47 1972; 18 1996; 9 2012; 9 Rodriguez (R5-15-20241201) 2012; 9 Miyazaki (R28-15-20241201) 2002; 283 Kang (R18-15-20241201) 2012; 47 Friedwald (R12-15-20241201) 1972; 18 ZelberSagi (R27-15-20241201) 2008; 48 Golan (R30-15-20241201) 2012; 35 Umpierre (R3-15-20241201) 2011; 305 Targher (R15-15-20241201) 2012; 35 Schwenzer (R31-15-20241201) 2009; 51 Hallsworth (R24-15-20241201) 2011; 60 Fishbein (R14-15-20241201) 1997; 15 Lee (R13-15-20241201) 1984; 153 Bozzetto (R23-15-20241201) 2012; 35 Magkos (R26-15-20241201) 2010; 21 Reeder (R32-15-20241201) 2011; 34 Karvonen (R11-15-20241201) 1957; 35 Bacchi (R10-15-20241201) 2012; 35 Targher (R1-15-20241201) 2010; 363 Shen (R20-15-20241201) 2003; 11 Tamura (R9-15-20241201) 2005; 90 McPherson (R17-15-20241201) 2009; 51 Cassidy (R19-15-20241201) 2009; 29 Johnson (R22-15-20241201) 2009; 50 Thoma (R4-15-20241201) 2012; 56 Szczepaniak (R16-15-20241201) 2005; 288 Sniderman (R29-15-20241201) 2007; 36 Johnson (R21-15-20241201) 1996; 9 Bonekamp (R6-15-20241201) 2008; 48 Harrison (R25-15-20241201) 2007; 56 Boule (R2-15-20241201) 2001; 286 23696196 - Hepatology. 2014 Jan;59(1):351-2 24516886 - Hepatology. 2014 Jan;59(1):352 |
References_xml | – volume: 35 start-page: 676 year: 2012 end-page: 682 article-title: Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study) publication-title: Diabetes Care – volume: 9 start-page: 726 year: 2012 end-page: 731 article-title: Physical activity: an essential component of lifestyle modification in NAFLD publication-title: Nat Rev Gastroenterol Hepatol – volume: 286 start-page: 1218 year: 2001 end-page: 1227 article-title: Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials publication-title: JAMA – volume: 288 start-page: E462 year: 2005 end-page: E468 article-title: Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population publication-title: Am J Physiol Endocrinol Metab – volume: 33 start-page: 2156 year: 2010 end-page: 2163 article-title: Effect of a 12‐month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes publication-title: Diabetes Care – volume: 59 start-page: 627 year: 2010 end-page: 633 article-title: Metabolic changes following a 1‐year diet and exercise intervention in patients with type 2 diabetes publication-title: Diabetes – volume: 15 start-page: 287 year: 1997 end-page: 293 article-title: Introduction of fast MR imaging in the assessment of hepatic steatosis publication-title: Magn Reson Imaging – volume: 48 start-page: 806A year: 2008 article-title: The effect of an exercise training intervention on hepatic steatosis [Abstract] publication-title: Hepatology – volume: 47 start-page: 368 year: 2012 end-page: 375 article-title: Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical‐shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard publication-title: Invest Radiol – volume: 33 start-page: e147 year: 2010 end-page: e167 article-title: Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement publication-title: Diabetes Care – volume: 29 start-page: 231 year: 2009 end-page: 260 article-title: Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis publication-title: Radiographics – volume: 35 start-page: 1429 year: 2012 end-page: 1435 article-title: Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients publication-title: Diabetes Care – volume: 56 start-page: 255 year: 2012 end-page: 266 article-title: Lifestyle interventions for the treatment of non‐alcoholic fatty liver disease in adults: a systematic review publication-title: J Hepatol – volume: 283 start-page: E1135 year: 2002 end-page: 1143 article-title: Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus publication-title: Am J Physiol Endocrinol Metab – volume: 9 start-page: 19 year: 1996 end-page: 24 article-title: The abdominal subcutaneous tissue: computed tomographic, magnetic resonance, and anatomical observations publication-title: Clin Anat – volume: 11 start-page: 5 year: 2003 end-page: 15 article-title: Adipose tissue quantification by imaging methods: a proposed classification publication-title: Obes Res – volume: 56 start-page: 1760 year: 2007 end-page: 1769 article-title: Benefits of lifestyle modification in NAFLD publication-title: Gut – volume: 363 start-page: 1341 year: 2010 end-page: 1350 article-title: Risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease publication-title: N Engl J Med – volume: 48 start-page: 1791 year: 2008 end-page: 1798 article-title: Role of leisure‐time physical activity in non‐alcoholic fatty liver disease: a population‐based study publication-title: Hepatology – volume: 50 start-page: 1105 year: 2009 end-page: 1112 article-title: Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss publication-title: Hepatology – volume: 51 start-page: 433 year: 2009 end-page: 445 article-title: Non‐invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance publication-title: J Hepatol – volume: 305 start-page: 1790 year: 2011 end-page: 1799 article-title: Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta‐analysis publication-title: JAMA – volume: 153 start-page: 195 year: 1984 end-page: 201 article-title: Fatty infiltration of the liver: demonstration by proton spectroscopic imaging publication-title: Preliminary observations. Radiology – volume: 34 start-page: 729 year: 2011 end-page: 749 article-title: Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy publication-title: J Magn Reson Imaging – volume: 60 start-page: 1278 year: 2011 end-page: 1283 article-title: Resistance exercise reduces liver fat and its mediators in non‐alcoholic fatty liver disease independent of weight loss publication-title: Gut – volume: 21 start-page: 507 year: 2010 end-page: 517 article-title: Exercise and fat accumulation in the human liver publication-title: Curr Opin Lipidol – volume: 90 start-page: 3191 year: 2005 end-page: 3196 article-title: Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type2 diabetic patients publication-title: J Clin Endocrinol Metab – volume: 35 start-page: 748 year: 2012 end-page: 753 article-title: Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals publication-title: J Endocrinol Invest – volume: 36 start-page: 220 year: 2007 end-page: 225 article-title: Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis publication-title: Int J Epidemiol – volume: 51 start-page: 389 year: 2009 end-page: 397 article-title: Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered publication-title: J Hepatol – volume: 35 start-page: 640 year: 2012 end-page: 647 article-title: Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes publication-title: Diabetes Care – volume: 35 start-page: 307 year: 1957 end-page: 315 article-title: The effects of training on heart rate; a longitudinal study publication-title: Ann Med Exp Biol Fenn – volume: 18 start-page: 499 year: 1972 end-page: 502 article-title: Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge publication-title: Clin Chem – volume: 283 start-page: E1135 year: 2002 ident: R28-15-20241201 article-title: Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.0327.2001 – volume: 18 start-page: 499 year: 1972 ident: R12-15-20241201 article-title: Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. publication-title: Clin Chem doi: 10.1093/clinchem/18.6.499 – volume: 51 start-page: 389 year: 2009 ident: R17-15-20241201 article-title: Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. publication-title: J Hepatol doi: 10.1016/j.jhep.2009.04.012 – volume: 34 start-page: 729 year: 2011 ident: R32-15-20241201 article-title: Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. publication-title: J Magn Reson Imaging doi: 10.1002/jmri.22580 – volume: 9 start-page: 19 year: 1996 ident: R21-15-20241201 article-title: The abdominal subcutaneous tissue: computed tomographic, magnetic resonance, and anatomical observations. publication-title: Clin Anat doi: 10.1002/(SICI)1098-2353(1996)9:1<19::AID-CA4>3.0.CO;2-V – volume: 51 start-page: 433 year: 2009 ident: R31-15-20241201 article-title: Noninvasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. publication-title: J Hepatol doi: 10.1016/j.jhep.2009.05.023 – volume: 35 start-page: 676 year: 2012 ident: R10-15-20241201 article-title: Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). publication-title: Diabetes Care doi: 10.2337/dc11-1655 – volume: 56 start-page: 1760 year: 2007 ident: R25-15-20241201 article-title: Benefits of lifestyle modification in NAFLD. publication-title: Gut doi: 10.1136/gut.2006.112094 – volume: 35 start-page: 748 year: 2012 ident: R15-15-20241201 article-title: Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals. publication-title: J Endocrinol Invest – volume: 48 start-page: 806A year: 2008 ident: R6-15-20241201 article-title: The effect of an exercise training intervention on hepatic steatosis Abstract. publication-title: Hepatology – volume: 56 start-page: 255 year: 2012 ident: R4-15-20241201 article-title: Lifestyle interventions for the treatment of nonalcoholic fatty liver disease in adults: a systematic review. publication-title: J Hepatol doi: 10.1016/j.jhep.2011.06.010 – volume: 15 start-page: 287 year: 1997 ident: R14-15-20241201 article-title: Introduction of fast MR imaging in the assessment of hepatic steatosis. publication-title: Magn Reson Imaging doi: 10.1016/S0730-725X(96)00224-X – volume: 47 start-page: 368 year: 2012 ident: R18-15-20241201 article-title: Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemicalshift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. publication-title: Invest Radiol doi: 10.1097/RLI.0b013e31824baff3 – volume: 90 start-page: 3191 year: 2005 ident: R9-15-20241201 article-title: Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type2 diabetic patients. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-1959 – volume: 11 start-page: 5 year: 2003 ident: R20-15-20241201 article-title: Adipose tissue quantification by imaging methods: a proposed classification. publication-title: Obes Res doi: 10.1038/oby.2003.3 – volume: 48 start-page: 1791 year: 2008 ident: R27-15-20241201 article-title: Role of leisuretime physical activity in nonalcoholic fatty liver disease: a populationbased study. publication-title: Hepatology doi: 10.1002/hep.22525 – volume: 21 start-page: 507 year: 2010 ident: R26-15-20241201 article-title: Exercise and fat accumulation in the human liver. publication-title: Curr Opin Lipidol doi: 10.1097/MOL.0b013e32833ea912 – volume: 305 start-page: 1790 year: 2011 ident: R3-15-20241201 article-title: Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and metaanalysis. publication-title: JAMA doi: 10.1001/jama.2011.576 – volume: 153 start-page: 195 year: 1984 ident: R13-15-20241201 article-title: Fatty infiltration of the liver: demonstration by proton spectroscopic imaging. Preliminary observations. publication-title: Radiology doi: 10.1148/radiology.153.1.6089264 – volume: 36 start-page: 220 year: 2007 ident: R29-15-20241201 article-title: Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. publication-title: Int J Epidemiol doi: 10.1093/ije/dyl245 – volume: 363 start-page: 1341 year: 2010 ident: R1-15-20241201 article-title: Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. publication-title: N Engl J Med doi: 10.1056/NEJMra0912063 – volume: 286 start-page: 1218 year: 2001 ident: R2-15-20241201 article-title: Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a metaanalysis of controlled clinical trials. publication-title: JAMA doi: 10.1001/jama.286.10.1218 – volume: 9 start-page: 726 year: 2012 ident: R5-15-20241201 article-title: Physical activity: an essential component of lifestyle modification in NAFLD. publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2012.200 – volume: 29 start-page: 231 year: 2009 ident: R19-15-20241201 article-title: Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. publication-title: Radiographics doi: 10.1148/rg.291075123 – volume: 50 start-page: 1105 year: 2009 ident: R22-15-20241201 article-title: Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. publication-title: Hepatology doi: 10.1002/hep.23129 – volume: 35 start-page: 307 year: 1957 ident: R11-15-20241201 article-title: The effects of training on heart rate; a longitudinal study. publication-title: Ann Med Exp Biol Fenn – volume: 35 start-page: 1429 year: 2012 ident: R23-15-20241201 article-title: Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. publication-title: Diabetes Care doi: 10.2337/dc12-0033 – volume: 288 start-page: E462 year: 2005 ident: R16-15-20241201 article-title: Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00064.2004 – volume: 60 start-page: 1278 year: 2011 ident: R24-15-20241201 article-title: Resistance exercise reduces liver fat and its mediators in nonalcoholic fatty liver disease independent of weight loss. publication-title: Gut doi: 10.1136/gut.2011.242073 – volume: 35 start-page: 640 year: 2012 ident: R30-15-20241201 article-title: Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes. publication-title: Diabetes Care doi: 10.2337/dc11-1583 – reference: 24516886 - Hepatology. 2014 Jan;59(1):352 – reference: 23696196 - Hepatology. 2014 Jan;59(1):351-2 |
SSID | ssj0009428 |
Score | 2.554632 |
Snippet | Although lifestyle interventions are considered the first‐line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with... Although lifestyle interventions are considered the first-line therapy for nonalcoholic fatty liver disease (NAFLD), which is extremely common in people with... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1287 |
SubjectTerms | Body Composition - physiology Comorbidity Confidence intervals Diabetes Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - metabolism Diabetes Mellitus, Type 2 - physiopathology Diet Exercise Fatty Liver - epidemiology Fatty Liver - metabolism Fatty Liver - physiopathology Female Hepatology Humans Insulin Insulin Resistance - physiology Intervention Lipid Metabolism - physiology Liver - metabolism Liver diseases Magnetic Resonance Imaging Male Middle Aged Non-alcoholic Fatty Liver Disease Resistance Training Subcutaneous Fat - pathology Treatment Outcome |
Title | Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial) |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.26393 https://www.ncbi.nlm.nih.gov/pubmed/23504926 https://www.proquest.com/docview/1439091111 https://www.proquest.com/docview/1443397943 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swELYQDxMvYxtsdGPTDfHQPaSkdkhs7YltRRUSCFVU6sOkyI4dUVECIunD-If2b-7O-VHBhoT2FtVO7Dp3vu98l-8Y21dJiKjeqCCxmQwiF2vcB60NEhcbtNeJ4f4LudOzeDyNTmaHszX2tf0WpuaH6A7cSDP8fk0Krk15sCINvXS3A472lZg-KVeLANFkRR2lIl9XFb2ukKLLqmUVCvlBd-dDW_QXwHyIV73BOd5kP9up1nkmV4NlZQbZ_SMWx__8L6_YywaIwlEtOa_ZmivesBenTah9i_3-hu8Q0BkngImSAW0xCdCFBe2Ivylb_XhHFLAOcAiigIVcV0BZ8GjSYF4AHfQCh_qgF5vLpaHznxLoGBgK8gZ8pd76zuoXLChdBJroEfQRpcLkaPSDA5pWe3M9v3cWfMGRL9tsejy6-D4OmqoOQSakFIGKNcJMmUTGmMxKI3M3lNpFxirtBCJAzYVFm4m7i8xDJRDfEQzURlpsdkq8Zes4L7fDQCinBZeZQicOjexQ8ziJbK6N0irnzvZYv32_adZQntO6LNKarJmnuCqpX_ge2-u63tY8H__qtNsKSdqoeom-k1AhmYxhj33umlFJKfKiC3ezpD6RoABqhI94VwtXNwoXhyGxNuJkvYg8PXw6Hp37i_fP7_qBbXAq4OHTD3fZenW3dB8RRlXmk9eXPya9GUs |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEXKO-FFgbEoRyyzdppYku9tLDVAt0KVa3USxXZsSMqSlp1swf6h_ibzDiPVXlIiFu0dmKvM-P5Zsb5BuCNzmJC9VZHmStUlPjU0D7oXJT51JK9zqwIX8hN99PJUfLxePN4Cba6b2Eafog-4MaaEfZrVnAOSG8sWEO_-IuhIAMrb8BNrugdHKqDBXmUTkJlVfK7Ys4v645XKBYb_a3XrdFvEPM6Yg0mZ_cenHSTbU6afB3Oazssrn7hcfzff7MCd1ssituN8NyHJV89gFvTNtv-EH7s0GtE8scZY5JwYFdPAk3l0HimcCoWP14yC6xHGoJZYLE0NfJBeLJqeFohx3pRYBPrpebZ3HIIaIYcCcaKHYJQrLe5s_6OZ3xiBNsEEq4TUMWD7fF7gWRd3fm30yvvMNQcefsIjnbHh-8mUVvYISqkUjLSqSGkqbLEWls4ZVXpR8r4xDptvCQQaIR0ZDZpg1FlrCVBPEaCxipHzV7Lx7BM8_JPAaX2RgpVaPLjyM6OjEizxJXGaqNL4d0A1rsXnBct6zmvy1ne8DWLnFYlDws_gNd914uG6uNPnVY7KclbbZ-R-yR1zFZjNIBXfTPpKSdfTOXP59wnkZxDTegRTxrp6kcRcjNm4kaabJCRvw-fT8afw8Wzf-_6Em5PDqd7-d6H_U_P4Y7geh7hNOIqLNeXc79GqKq2L4Ly_ASiHR1m |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVceFMWCgyIQzlkm7XTxBanwu5qebSqKir1gBTZsSMqSrrqZg_0D_E3mXEeq_KQELdo7cReZ8bzzYzzDcBLncWE6q2OMleoKPGpoX3QuSjzqSV7nVkRvpDbP0hnx8n7k92TNXjdfQvT8EP0ATfWjLBfs4LPXbmzIg394udDQfZVXoPrSRorFunx0Yo7SiehsCq5XTGnl3VHKxSLnf7Wq8boN4R5FbAGizO9BZ-7uTYHTb4Ol7UdFpe_0Dj-55-5DTdbJIp7jejcgTVf3YWN_TbXfg9-vKGXiOSNM8Ik0cCumgSayqHxTOBUrH68YA5YjzQEc8BiaWrkY_Bk0_C0Qo70osAm0kvNi6XlANACOQ6MFbsDoVRvc2f9Hc_4vAi26SPcJpiKR3uTsUCyre782-mldxgqjry6D8fTyae3s6gt6xAVUikZ6dQQzlRZYq0tnLKq9CNlfGKdNl4SBDRCOjKatL2oMtaSAB7jQGOVo2av5QNYp3n5h4BSeyOFKjR5cWRlR0akWeJKY7XRpfBuANvd-82LlvOc1-Usb9iaRU6rkoeFH8CLvuu8Ifr4U6etTkjyVtcX5DxJHbPNGA3ged9MWsqpF1P58yX3SSRnUBN6xGYjXP0oQu7GTNtIkw0i8vfh89nkMFw8-veuz2DjcDzNP747-PAYbggu5hGOIm7Ben2x9E8IUtX2aVCdn1YuHB4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Both+resistance+training+and+aerobic+training+reduce+hepatic+fat+content+in+type+2+diabetic+subjects+with+nonalcoholic+fatty+liver+disease+%28the+RAED2+randomized+trial%29&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Bacchi%2C+Elisabetta&rft.au=Negri%2C+Carlo&rft.au=Targher%2C+Giovanni&rft.au=Faccioli%2C+Niccol%C3%B2&rft.date=2013-10-01&rft.issn=0270-9139&rft.eissn=1527-3350&rft.volume=58&rft.issue=4&rft.spage=1287&rft.epage=1295&rft_id=info:doi/10.1002%2Fhep.26393&rft.externalDBID=10.1002%252Fhep.26393&rft.externalDocID=HEP26393 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon |